<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-pharmaceutics-10-00257" class="ref">
 <label class="label">19.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Rutckeviski</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Xavier-Junior</surname>
    <given-names class="given-names">F.H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Morais</surname>
    <given-names class="given-names">A.R.V.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Amaral-Machado</surname>
    <given-names class="given-names">L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Alencar</surname>
    <given-names class="given-names">E.N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Genre</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Araujo</surname>
    <given-names class="given-names">A.A.S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Egito</surname>
    <given-names class="given-names">E.S.T.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Therapeutic bullfrog oil-based nanoemulsion for oral application: Development, characterization and stability</article-title>
  <source class="source">Acta Pharm.</source>
  <year class="year">2018</year>
  <comment class="comment">in press</comment>
 </element-citation>
</ref>
